Pfizer's COVID-19 antiviral pill will already have some competition in the US. As the Associated Press reports, the Food and Drug Administration has given…
One source of comfort is that the treatment course’s brevity—four pills twice a day for five days—means there is less opportunity for resistance to develop,…